Gertel, Smadar <br/><br/>
Tofacitinib attenuates arthritis manifestations and reduces the pathogenic CD4 T cells in adjuvant arthritis rats.  [electronic resource] 

 -  Clinical immunology (Orlando, Fla.)  11 2017 
 - 77-81 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-7035 
<br/><br/><label>Standard No.: </label>10.1016/j.clim.2017.04.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antirheumatic Agents--pharmacology<br/>Arthritis, Experimental--immunology<br/>Arthritis, Rheumatoid--immunology<br/>C-Reactive Protein--drug effects<br/>CD4-Positive T-Lymphocytes--drug effects<br/>Foot<br/>Foot Joints--drug effects<br/>Forelimb<br/>Hindlimb<br/>Interferon-gamma--immunology<br/>Interleukin-1beta--drug effects<br/>Methotrexate--pharmacology<br/>Piperidines--pharmacology<br/>Protein Kinase Inhibitors--pharmacology<br/>Pyrimidines--pharmacology<br/>Pyrroles--pharmacology<br/>RNA, Messenger--drug effects<br/>Rats<br/>Real-Time Polymerase Chain Reaction<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Spleen--cytology